71 related articles for article (PubMed ID: 1353693)
1. The action of interferon alpha on human carcinoid tumours.
Oberg K
Semin Cancer Biol; 1992 Feb; 3(1):35-41. PubMed ID: 1353693
[TBL] [Abstract][Full Text] [Related]
2. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
[TBL] [Abstract][Full Text] [Related]
3. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.
Grandér D; Oberg K; Lundqvist ML; Janson ET; Eriksson B; Einhorn S
Lancet; 1990 Aug; 336(8711):337-40. PubMed ID: 1975335
[TBL] [Abstract][Full Text] [Related]
5. Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells.
Warner SJ; Friedman GB; Libby P
J Clin Invest; 1989 Apr; 83(4):1174-82. PubMed ID: 2495301
[TBL] [Abstract][Full Text] [Related]
6. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro.
Angus R; Collins CM; Symes MO
Eur J Cancer; 1993; 29A(13):1879-85. PubMed ID: 8260246
[TBL] [Abstract][Full Text] [Related]
7. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
8. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours.
Zhou Y; Gobl A; Wang S; Jacobsen MB; Janson ET; Haines GK; Radosevich JA; Oberg K
Eur J Cancer; 1998 Dec; 34(13):2046-52. PubMed ID: 10070309
[TBL] [Abstract][Full Text] [Related]
9. [Demonstration of an interferon alpha receptor in human colonic cancer cells in culture].
Boissard C; Chelbi Alix MK; Gali P; Thang MN; Rosselin G
C R Acad Sci III; 1989; 309(11):485-92. PubMed ID: 2533880
[TBL] [Abstract][Full Text] [Related]
10. Cell and type specificity of interferon action. Unusual characteristics of the transcriptional control of gene expression by interferon-gamma in T cells.
Gribaudo G; Gariglio M; Cavallo G; Landolfo S
Eur J Immunol; 1990 Jun; 20(6):1243-9. PubMed ID: 2114996
[TBL] [Abstract][Full Text] [Related]
11. Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon.
Gothelf Y; Raber J; Chen L; Schattner A; Chebath J; Revel M
Lymphokine Cytokine Res; 1991 Oct; 10(5):369-75. PubMed ID: 1768740
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
[TBL] [Abstract][Full Text] [Related]
13. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
Bourgeade MF; Besançon F
Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
[TBL] [Abstract][Full Text] [Related]
17. Measurement of interferon sensitivity in tumour cells from fine-needle aspirations.
Grandér D; Skoog L; Tani E; Einhorn S
Eur J Cancer; 1992; 28A(4-5):815-8. PubMed ID: 1524900
[TBL] [Abstract][Full Text] [Related]
18. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.
Wängberg B; Nilsson O; Theodorsson E; Dahlström A; Ahlman H
Br J Cancer; 1991 Jul; 64(1):23-8. PubMed ID: 1713051
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
Ferbus D; Khosravi S; Dumont J; Billard C
J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
